Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter‐Defibrillators in the Cardiovascular Research Network

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter‐Defibrillators in the Cardiovascular Research Network

BackgroundPrimary prevention implantable cardioverter‐defibrillators (ICDs) reduce mortality in selected patients with left ventricular systolic dysfunction by delivering therapies (antitachycardia pacing or shocks) to terminate potentially lethal arrhythmias; inappropriate therapies also occur. We...

Full description

Bibliographic Details
Main Authors: Robert T. Greenlee, Alan S. Go, Pamela N. Peterson, Andrea E. Cassidy‐Bushrow, Charles Gaber, Romel Garcia‐Montilla, Karen A. Glenn, Nigel Gupta, Jerry H. Gurwitz, Stephen C. Hammill, John J. Hayes, Alan Kadish, David J. Magid, David D. McManus, Deborah Multerer, J. David Powers, Liza M. Reifler, Kristi Reynolds, Claudio Schuger, Param P. Sharma, David H. Smith, Mary Suits, Sue Hee Sung, Paul D. Varosy, Humberto J. Vidaillet, Frederick A. Masoudi
Format: Article
Language:English
Published: Wiley 2018-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
arrhythmia
implantable cardioverter‐defibrillator
inappropriate shock
outcomes research
sudden cardiac death
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.008292

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.008292

Similar Items